Gsk (GSK) Other Gross PP&E Adjustments (2019 - 2026)

Gsk's Other Gross PP&E Adjustments history runs 8 years deep, the most recent figure standing at -$941.0 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments rose 8.55% year-over-year to -$941.0 million; the TTM figure through Mar 2026 stood at -$941.0 million (up 8.55% YoY), while the FY2025 annual figure was -$957.2 million, up 11.48% from the prior year.
• Other Gross PP&E Adjustments was -$941.0 million for Q1 2026 at Gsk, up from -$965.7 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of -$134.2 million in Q1 2022 to a low of -$1.2 billion in Q4 2023.
• Historically, Other Gross PP&E Adjustments has averaged -$923.5 million across 5 years, with a median of -$965.7 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Other Gross PP&E Adjustments surged 87.7% in 2022, then slumped 494.24% in 2023.
• A 5-year view of Other Gross PP&E Adjustments shows it stood at -$805.8 million in 2022, then slumped by 44.32% to -$1.2 billion in 2023, then advanced by 6.63% to -$1.1 billion in 2024, then advanced by 11.06% to -$965.7 million in 2025, then advanced by 2.55% to -$941.0 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$941.0 million (Q1 2026), -$965.7 million (Q4 2025), and -$1.1 billion (Q3 2025), per Business Quant data.